Atypical antipsychotic monitoring in the Kilkenny Mental Health Services

Irish Journal of Psychological Medicine

Volumn 22, Issue 3, 2005, Pages 101-102

  Feeney, Larkin ^a   Mooney, Mary ^b  

^a General Adult Psychiatry

^b St Lukes General Hospital Kilkenny   (Ireland)

Author keywords

Atypical antipsychotic monitoring; Baseline testing; Mental health services

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; FERRITIN; GLUCOSE; HEMOGLOBIN A1C; PROLACTIN;

ARTICLE; BASAL METABOLIC RATE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; HOSPITAL PATIENT; HUMAN; IRELAND; MENTAL HEALTH SERVICE; PRESCRIPTION; PSYCHOSIS; RISK FACTOR; WEIGHT GAIN;

EID: 25844440520     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700009113     Document Type: Article

References (8)

1. Almeras N, Despres JP, Villeneuve J, Demers MF, Roy MA, Cadrin C, Mottard JP, Bouchard RH. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry. 2004; 65 (4): 557-64.
2. Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res. 2004; 70 (1): 1-17.
3. Nasrallah HA, Newcomer JW. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. J Clin Psychopharmacol. 2004; 24 (5 Suppl 1), S7-14.
4. Chue P, Kovacs CS. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management. Bipolar Disord 2003; 5 (2): 62-79.
5. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kne JM, Liebermn JA, Schooler NR, Covell N, Stroup S, Weisman EM, Wirshing DA, Hall Cs, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161 (8): 1334-1349.
6. Taylor D, Paton C, Kerwin R. The Maudsley 2003 Prescribing Guidelines. London: Martin Dunitz, 2003.
7. Kane JM, Leucht S, Carpenter D, Docherty JP. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry 2003; 64(12): 5-19.
8. Dinan TG and expert group. "Schizophrenia and diabetes 2003" Expert consensus meeting, Dublin, 3-4 October 2003: consensus summary. Br J Psychiatry 2004; 184 (suppl. 47): s112-s114.